You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

newly-diagnosed t-AML or AML-MRC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

Not yet recruiting
  • Acute Myeloid Leukemia in Children
  • Standard Intervention
  • Investigational Intervention
  • (no location specified)
Aug 8, 2023

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • (no location specified)
Apr 24, 2023

Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    Sep 22, 2023

    Acute Myeloid Leukemia Trial in Kunming (Venetoclax in combination with azacitidine and CAG)

    Recruiting
    • Acute Myeloid Leukemia
    • Venetoclax in combination with azacitidine and CAG
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Dec 20, 2022

    Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Vienna, Austria
    • +3 more
    Jun 8, 2023

    UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Wuhan (Basic

    Recruiting
    • UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
    • Basic chemotherapy + UCB transplantation
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Oct 9, 2022

    FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia Trial (midostaurin)

    Available
    • FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia
    • (no location specified)
    Oct 18, 2022

    Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen

    Not yet recruiting
    • Leukemia, Myeloid, Acute
    • AML Stage, Adult
    • Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
    • Xiamen, Fujian, China
      Bing Xu
    Oct 29, 2022

    Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)

    Recruiting
    • Newly Diagnosed Acute Myeloid Leukemia (AML)
    • SKLB1028 Dose Escalation
    • Chengdu, China
      West China Hospital of Sichuan University
    Jun 30, 2022

    AML, Adult Trial in Netherlands (azacitidine, Venetoclax, Cobicistat)

    Not yet recruiting
    • AML, Adult
    • Amersfoort, Netherlands
    • +17 more
    Aug 23, 2023

    Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)

    Recruiting
    • Acute Myeloid Leukemia
    • Azacitidine Combined With Venetoclax and ATRA group
    • Suzhou, China
      the First Affiliated Hospital of Soochow University
    Dec 8, 2022

    Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Suzhou, Jiangsu, China
      Qiu Huiying
    Mar 28, 2023

    Acute Myeloid Leukemia (AML) Trial in Tianjin (Quizartinib)

    Completed
    • Acute Myeloid Leukemia (AML)
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    Jul 27, 2022

    Acute Myeloid Leukemia Trial in Germany (Venetoclax plus Azacitidine, standard of care chemo plus gemtuzumab ozogamicin)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Venetoclax plus Azacitidine
    • standard of care chemotherapy plus gemtuzumab ozogamicin
    • Essen, NRW, Germany
    • +17 more
    Jun 6, 2023

    Acute Myeloid Leukemia Trial (Tagraxofusp (Cycles 1-2), Azacitidine, Tagraxofusp (Cycles 3-12))

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Tagraxofusp (Cycles 1-2)
    • +2 more
    • (no location specified)
    Jun 28, 2022

    AML, Adult Trial in Chicago, Charlottesville (BST-236, venetoclax)

    Recruiting
    • AML, Adult
    • Chicago, Illinois
    • +1 more
    Aug 17, 2022

    Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Different induction chemotherapy regimens
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Sep 27, 2023

    Acute Myeloid Leukemia Trial in Tampa (Vyxeos, Gemtuzumab Ozogamicin)

    Recruiting
    • Acute Myeloid Leukemia
    • Tampa, Florida
      Moffitt Cancer Center
    Sep 23, 2022

    Acute Myeloid Leukemia Trial in Baltimore, Chapel Hill, Charleston (pembrolizumab, Azacitadine)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Baltimore, Maryland
    • +2 more
    May 19, 2022

    Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

    Recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Biospecimen Collection
    • +3 more
    • Baltimore, Maryland
    • +2 more
    Jan 19, 2023

    Acute Myeloid Leukemia Trial (Quizartinib, Treatment according to Physician's Choice, Standard of Care Chemotherapy)

    Withdrawn
    • Acute Myeloid Leukemia
    • (no location specified)
    May 18, 2022

    AML Trial (APVO436)

    Withdrawn
    • AML
    • APVO436
    • (no location specified)
    Nov 29, 2021

    Leukemia, Myeloid, Acute Trial in Jerusalem (Vyxeos, Mylotarg)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Jerusalem, Yerushalayim, Israel
      Shaare Zedek Medical Center
    Oct 25, 2022

    AML, Hyperleukocytosis Trial in Monterrey (Vinblastine, Hydroxyurea capsules)

    Recruiting
    • AML
    • Hyperleukocytosis
    • Monterrey, Nuevo Leon, Mexico
      Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
    Oct 9, 2021

    Acute Myeloid Leukemia, Venetoclax Trial in Kunming (combination of venetoclax and HAA regimen)

    Recruiting
    • Acute Myeloid Leukemia
    • Venetoclax
    • combination of venetoclax and HAA regimen
    • Kunming, Yunnan, China
      The Second Affiliated Hospital of Kunming Medical University.
    May 29, 2023